Skip to main content
Sequoia Logo

BridgeBio develops breakthrough medicines for genetic diseases. Its portfolio of more than 15 drugs, all in various stages of development, addresses everything from genetic skin, cancer- and heart-related issues to renal disease.

Healthcare
  • Founded 2014
  • Partnered 2018
  • IPO 2019